Lifeward Ltd. (LFWD): Form 8-K filed 2026-11-13
- Accepted by EDGAR
- 2026-11-13 09:25 ET
- Event date
- 2026-11-13
- Accession no.
- 0001178913-26-005208
- Original filing
- SEC EDGAR filing index
AI summary of the filing text. It can contain mistakes; the original filing is authoritative.
Lifeward reports third-quarter revenue of $5.4 million and net loss of $5.1 million
Lifeward reported revenue of $5.4 million for the third quarter ended September 30, 2026, down 12%, and a net loss of $5.1 million. AlterG revenue increased 18% to $3.6 million, while ReWalk Personal exoskeleton revenue declined to $1.7 million from $3.0 million. The company is shifting ReWalk from direct sales to a channel-partner distribution model.
- Third-quarter revenue was $5.4 million, compared to $6.2 million in the third quarter of 2025, a decrease of 12%.
- Net loss was $5.1 million, or $1.32 per share, compared to $3.2 million, or $2.37 per share, in the prior-year quarter.
- AlterG revenue increased 18% year-over-year to $3.6 million.
- Unrestricted cash and cash equivalents were $4.5 million as of September 30, 2026.
earnings
Items reported
- Item 2.02: Results of Operations and Financial Condition
The company publicly announced results of operations or financial condition for a completed period, most often a quarterly earnings release. The release itself is usually attached as Exhibit 99.1. Information under Item 2.02 is generally "furnished" rather than "filed". - Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | zk2636410.htm |
| EX-99.1 | EXHIBIT 99.1 | exhibit_99-1.htm |
The summary above was generated by AI from the filing text and checked automatically against it. Read the original documents on SEC EDGAR. How to read an 8-K.